YF-2
Catalog No. A21018
YF-2 is a highly selective, blood-brain-barrier permeable histone acetyltransferase activator, acetylates H3 in the hippocampus, with EC50s of 2.75 μM, 29.04 μM and 49.31 μM for CBP, PCAF, and GCN5, respectively, shows no effect on HDAC. Anti-cancer and anti-Alzheimer's disease.
Catalog Num | A21018 |
---|---|
M. Wt | 430.85 |
Formula | C20H22ClF3N2O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1311423-89-8 |
Synonyms | YF2, YF 2 |
SMILES | O=C(NC1=CC=C(Cl)C(C(F)(F)F)=C1)C2=C(OCC)C=CC=C2OCCN(C)C |
YF-2 is a highly selective, blood-brain-barrier permeable histone acetyltransferase activator, acetylates H3 in the hippocampus, with EC50s of 2.75 μM, 29.04 μM and 49.31 μM for CBP, PCAF, and GCN5, respectively, shows no effect on HDAC. Anti-cancer and anti-Alzheimer's disease.
In vitro | DMSO | 78 mg/mL (181.03 mM) | |
Water | 78 mg/mL (181.03 mM) | ||
Ethanol | 78 mg/mL (181.03 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.21 mL | 116.05 mL | 232.1 mL |
0.5 mM | 4.64 mL | 23.21 mL | 46.42 mL |
1 mM | 2.32 mL | 11.6 mL | 23.21 mL |
5 mM | 0.46 mL | 2.32 mL | 4.64 mL |
*The above data is based on the productmolecular weight 430.85. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.